Showing 1 - 5 results of 5 for search 'Pope Kosalaraksa', query time: 0.02s Refine Results
  1. 1
    Serum procalcitonin and procalcitonin clearance as a prognostic biomarker of sepsis in a pediatric critical care setting: A tertiary care experience 2016-2021.

    Serum procalcitonin and procalcitonin clearance as a prognostic biomarker of sepsis in a pediatric critical care setting: A tertiary care experience 2016-2021. by Rattapon Uppala, Phanthila Sitthikarnkha, Apichaya Kriengwatanasiri, Leelawadee Techasatian, Suchaorn Saengnipanthkul, Sirapoom Niamsanit, Pope Kosalaraksa

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era.

    Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era. by Rattapon Uppala, Phanthila Sitthikarnkha, Kiatichai Faksri, Pope Kosalaraksa, Leelawadee Techasatian, Nattakarn Tantawarak, Sysavanh Nanthavongsa

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial

    Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial by Emmanuel Feroldi, Chitsanu Pancharoen, Pope Kosalaraksa, Veerachai Watanaveeradej, Kerdpanich Phirangkul, Maria R. Capeding, Mark Boaz, Sophia Gailhardou, Alain Bouckenooghe

    Published 2012-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    TAK-003: development of a tetravalent dengue vaccine

    TAK-003: development of a tetravalent dengue vaccine by Xavier Sáez-Llorens, Rodrigo DeAntonio, Jenny Guek Hong Low, Pope Kosalaraksa, Hansi Dean, Mayuri Sharma, Vianney Tricou, Shibadas Biswal

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg

    Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg by Eva Natukunda, Aditya H. Gaur, Pope Kosalaraksa, Elizabeth Hellström, Renate Strehlau, Afaaf Liberty, Stephanie Cox, Rory Leisegang, Ramesh Palaparthy, Susanne Crowe, Vinicius Vieira, Kathryn Kersey, Natella Rakhmanina

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: